XS-04

N/A

Report date: 2024/09/26 17:39:15
NME

Base Information

Drug NameXS-04
Drug Alias NameXS-04
ClassificationSmall molecules
Mechanisms of ActionInterleukin-1 receptor-associated kinase 4 inhibitorsTyrosine-protein kinase BTK inhibitors
TargetsInterleukin-1 receptor-associated kinase 4Tyrosine-protein kinase BTK
Therapy Area/IndicationsHematologic NeoplasmsLymphoma, Large B-Cell, Diffuse
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Xingsheng Xinhui Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Xingsheng Xinhui Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsLymphoma, Large B-Cell, Diffuse
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A